Publication: 664

Publication: 664

Tamoxifen Pharmacogenetics of CYP2D6, CYP2C19, and SULTIA1: Long Term Follow-up of the North Central Cancer Treatment Group 89-30-52 Adjuvant Trial.

URL

Google Scholar

Citation:: Cancer Res vol 69 (2, suppl 1) abstr SABCS-6037

Meeting Instance:: SABCS 2009
Year:: 2009
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 292

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: M. Goetz V. Suman M. Ames J. Black S. Safgren M. Kuffel R. Avula A. Moyer R. Weinshilboum C. Reynolds E. Perez J. Ingle

Networks:

Study: NCCTG-89-30-52
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: